Concepedia

Publication | Open Access

TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling

162

Citations

34

References

2022

Year

References

YearCitations

Page 1